Agriculture & Agritech Global On demand · 24-48h

Global Industrial Hemp Market Strategic Research Report

Global Industrial Hemp Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Industrial Hemp Market
$4812025
13.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: CBD Oil, CBD Crystal

By Application: Medical and Pharmaceutical, Food and Beverage, Cosmetics, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Kazmira, KND Labs, Aurora Cannabis, Canopy Growth Corporation, Endoca, Charlotte's Web CBD, CV Sciences, Sequoya, Mile High Labs, EcoGen Biosciences, Medical Marijuana, Inc., Yunnan Hempson Bio-Tech, Tengchong Chenguang Yunma Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 121 pages
Market size 2025
$481
Million USD
Forecast CAGR
13.9%
2025-2032
Forecast 2032
$1196.2
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Industrial Hemp market size is predicted to grow from US$ 481 million in 2025 to US$ 1,187 million in 2032; it is expected to grow at a CAGR of 13.9% from 2026 to 2032.

The industrial hemp counted in this report refers to the original plants of the genus Cannabis and their extracted products with a tetrahydrocannabinol content of less than 0.3% (percentage by dry matter weight).

Cannabis is a non-psychoactive compound increasingly used in health and wellness, cosmetics, food & beverage, and pharmaceutical products. The global cannabis market has grown rapidly in recent years due to increasing consumer awareness, evolving regulations, and demand for natural remedies. North America dominates the market, but Asia-Pacific and Europe are emerging as high-potential regions.

Market Trends：

Expansion of Legalization Worldwide: More countries and states are legalizing hemp-derived CBD for medical and wellness uses.

Product Diversification: cannabis is being integrated into various products such as gummies, capsules, beverages, skincare, and pet care.

Growth in E-commerce Channels: Online platforms have become key distribution channels, especially post-COVID-19.

Rising Investment in R&D: Companies are investing in clinical trials, product innovation, and purity enhancement.

Market Barriers：

Regulatory Uncertainty and Variability: Differences in legality, labeling, and THC content limits create compliance complexity.

Quality Control and Standardization Issues: Inconsistent product quality due to lack of uniform manufacturing standards.

Public Misconceptions and Stigma: Association with marijuana hampers broader market acceptance in some regions.

High Cost of Extraction and Purification: Advanced processing technologies such as CO₂ extraction are costly and require expertise.

This report presents a comprehensive overview of the global Industrial Hemp market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • CBD Oil
  • CBD Crystal

Segment by Application

  • Medical and Pharmaceutical
  • Food and Beverage
  • Cosmetics
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Industrial Hemp market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medical and Pharmaceutical, Food and Beverage, Cosmetics evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Industrial Hemp Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 13.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$481
2025
Forecast
$1196.2
2032
CAGR
13.9%
2025–2032
Regionen
5
global
Key companies
KazmiraKND LabsAurora CannabisCanopy Growth CorporationEndocaCharlotte's Web CBDCV SciencesSequoya
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
CBD OilCBD Crystal
By Application
Medical and PharmaceuticalFood and BeverageCosmeticsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 CBD Oil
  • 3.1.3 CBD Crystal
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medical and Pharmaceutical
  • 4.1.3 Food and Beverage
  • 4.1.4 Cosmetics
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Kazmira
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 KND Labs
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Aurora Cannabis
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Canopy Growth Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Endoca
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Charlotte's Web CBD
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 CV Sciences
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Sequoya
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Mile High Labs
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 EcoGen Biosciences
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Medical Marijuana, Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Yunnan Hempson Bio-Tech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Tengchong Chenguang Yunma Biotechnology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Industrial Hemp market size?
The global Industrial Hemp market is estimated at US$ 481 million in 2025 (base year) and is projected to reach US$ 1.19 billion by 2032.
What growth rate is expected for the Industrial Hemp market through 2032?
The market is expected to grow at a CAGR of 13.9% from 2026 to 2032, expanding from US$ 481 million in 2025 to US$ 1.19 billion in 2032, roughly 2.5 times its base-year value.
How is Industrial Hemp defined?
The industrial hemp counted in this report refers to the original plants of the genus Cannabis and their extracted products with a tetrahydrocannabinol content of less than 0.3% (percentage by dry matter weight).
How is the Industrial Hemp market segmented by type?
By type, the market is segmented into CBD Oil and CBD Crystal.
What are the key applications of Industrial Hemp?
Key applications covered include Medical and Pharmaceutical, Food and Beverage, Cosmetics and Other.
Which companies are profiled in the Industrial Hemp market report?
Key players profiled include Kazmira, KND Labs, Aurora Cannabis, Canopy Growth Corporation, Endoca, Charlotte's Web CBD, CV Sciences and Sequoya, among 13 companies covered in total.
What geographies does the Industrial Hemp market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Industrial Hemp market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medical and Pharmaceutical, Food and Beverage and Cosmetics, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Industrial Hemp market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.